Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First report of the use of mucosal swabs of the palatine tonsillar crypt for detection of <i>Mycoplasma bovis</i> in naturally infected calves.

New Zealand veterinary journal·2020
Same author

Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.

Parkinsonism & related disorders·2014
Same author

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Neurology·2012
Same author

Dynamics of C6 astrocytoma invasion into three-dimensional collagen gels.

Journal of neuro-oncology·2001
Same author

The A20R protein is a stoichiometric component of the processive form of vaccinia virus DNA polymerase.

Journal of virology·2001
Same author

Prenatal and breast milk morphine exposure following maternal intrathecal morphine treatment.

Journal of human lactation : official journal of International Lactation Consultant Association·2001
Same journal

Direct primary care may become the norm.

Medical economics·2016
Same journal

Independent doctors find success with physician-led ACOs.

Medical economics·2016
Same journal

Bundled pay brings physicians greater risks and rewards.

Medical economics·2016
Same journal

Discharging problem patients the right way.

Medical economics·2016
Same journal

How cyberattacks can impact physicians.

Medical economics·2016
Same journal

What active patient management means when billing incident-to.

Medical economics·2016
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling
05:43

Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

Published on: April 19, 2024

Fee adjustment in prolonged cases

W McDONALD

    Medical Economics
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    ECONOMICS, MEDICAL

    Related Experiment Videos

    Last Updated: Jun 15, 2026

    Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling
    05:43

    Determination of Continuity Index Values in Atrial Fibrillation Ablation with Proactive Esophageal Cooling

    Published on: April 19, 2024